Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
report source : Www.vynetherapeutics.com save search
VYNE Therapeutics Reports Year-End 2022 Financial Results and Provides Business Update
Published: 2023-03-09 (Crawled : 23:00) - vynetherapeutics.com
DERM | $3.52 -1.68% 65K
|
|
| O: -3.33%
H: 6.9%
C: 3.45%
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -1.31%
H: 1.32%
C: -0.66%
therapeutics financial update results
VYNE Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update
Published: 2022-11-10 (Crawled : 22:00) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: 8.28%
H: 0.0%
C: -6.26%
therapeutics financial update results
VYNE Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-12 (Crawled : 22:00) - vynetherapeutics.com
DERM | $3.52 -1.68% 65K
|
|
| O: 0.0%
H: 5.79%
C: 4.27%
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -2.45%
H: 8.11%
C: 0.32%
therapeutics results
VYNE Reports Positive Preclinical Data for Intra-Articular Injection of Pan-BET Inhibitor, VYN201, in an In Vivo Model of Rheumatoid Arthritis
Published: 2022-03-30 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -0.81%
H: 10.86%
C: 7.89%
vyn201 preclinical positive injection pre-clinical
VYNE Therapeutics Reports Year-End 2021 Financial Results and Provides Corporate Update
Published: 2022-03-17 (Crawled : 12:30) - vynetherapeutics.com
DERM | $3.52 -1.68% 65K
|
|
| O: 1.76%
H: 4.32%
C: -2.81%
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: 0.0%
H: 8.8%
C: 6.09%
financial results therapeutics report results
VYNE Reports Positive Preclinical Data for Lead BET Inhibitor, VYN201, in Human Skin Model of Vitiligo
Published: 2022-03-07 (Crawled : 12:30) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -1.09%
H: 4.04%
C: 0.12%
vyn201 pos skin preclinical report positive pre-clinical
VYNE Therapeutics to Report Third Quarter 2021 Financial Results on November 10, 2021
Published: 2021-10-28 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: 1.59%
financial results results
VYNE Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
Published: 2021-05-06 (Crawled : 12:00) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -7.08%
H: 1.43%
C: -15.24%
financial results results
VYNE Therapeutics to Report First Quarter 2021 Financial Results on May 6, 2021
Published: 2021-04-28 (Crawled : 13:00) - vynetherapeutics.com
VYNE | $2.29 -0.43% 12K
|
Health Technology
|
| O: -0.19%
H: 1.73%
C: 0.0%
financial results results
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.305 226.25% 130M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.